Last Updated: May 3, 2026

DUODOTE Drug Patent Profile

✉ Email this page to a colleague

When do Duodote patents expire, and what generic alternatives are available?

Duodote is a drug marketed by MMT and is included in one NDA.

The generic ingredient in DUODOTE is atropine; pralidoxime chloride. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the atropine; pralidoxime chloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for DUODOTE?
What are the global sales for DUODOTE?
What is Average Wholesale Price for DUODOTE?

Summary for DUODOTE

US Patents:	0
Applicants:	1
NDAs:	1

US Patents and Regulatory Information for DUODOTE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mmt	DUODOTE	atropine; pralidoxime chloride	INJECTABLE;INTRAMUSCULAR	021983-001	Sep 28, 2006		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for DUODOTE

See the table below for patents covering DUODOTE around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Germany	69126661		⤷ Start Trial
European Patent Office	0525048	AUTO-INJECTEUR DE DISPERSION A PLUSIEURS CHAMBRES (DISPERSION MULTI-CHAMBER AUTO-INJECTOR)	⤷ Start Trial
World Intellectual Property Organization (WIPO)	9116094		⤷ Start Trial
Australia	7675591		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.